ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oncology Targeted Therapy Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-6M13445
Home | Market Reports | Health| Health Conditions| Cancer
Global Oncology Targeted Therapy Market Research Report 2023
BUY CHAPTERS

Global Oncology Targeted Therapy Market Research Report 2025

Code: QYRE-Auto-6M13445
Report
January 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
Eisai Co Ltd
Zelgen
Cipla Ltd
Natco Pharma
Astrazeneca plc
Novartis
Roche
Bristol–Myers Squibb
Pfizer Inc
Beacon Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
Chiatai Tianqing
Simcere

Oncology Targeted Therapy Market Size

The global market for Oncology Targeted Therapy was valued at US$ 61670 million in the year 2024 and is projected to reach a revised size of US$ 113940 million by 2031, growing at a CAGR of 9.3% during the forecast period.

Oncology Targeted Therapy Market

Oncology Targeted Therapy Market

Targeted therapy is a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oncology Targeted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Targeted Therapy.
The Oncology Targeted Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology Targeted Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Targeted Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Oncology Targeted Therapy Market Report

Report Metric Details
Report Name Oncology Targeted Therapy Market
Accounted market size in year US$ 61670 million
Forecasted market size in 2031 US$ 113940 million
CAGR 9.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Retail Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche, Bristol-Myers Squibb, Pfizer, BEACON Pharma, Jiangxi Shanxiang, Yao Pharma, CSPC, CHIATAI Tianqing, Simcere
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Oncology Targeted Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Oncology Targeted Therapy Market growing?

Ans: The Oncology Targeted Therapy Market witnessing a CAGR of 9.3% during the forecast period 2025-2031.

What is the Oncology Targeted Therapy Market size in 2031?

Ans: The Oncology Targeted Therapy Market size in 2031 will be US$ 113940 million.

Who are the main players in the Oncology Targeted Therapy Market report?

Ans: The main players in the Oncology Targeted Therapy Market are Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche, Bristol-Myers Squibb, Pfizer, BEACON Pharma, Jiangxi Shanxiang, Yao Pharma, CSPC, CHIATAI Tianqing, Simcere

What are the Application segmentation covered in the Oncology Targeted Therapy Market report?

Ans: The Applications covered in the Oncology Targeted Therapy Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Oncology Targeted Therapy Market report?

Ans: The Types covered in the Oncology Targeted Therapy Market report are Sorafenib, Lenvatinib, Regorafenib, Osimertinib, Anlotinib, Alectinib, Other

Recommended Reports

Targeted Cancer Therapy

Cancer Treatment Devices

Oncology Drug Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Targeted Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Sorafenib
1.2.3 Lenvatinib
1.2.4 Regorafenib
1.2.5 Osimertinib
1.2.6 Anlotinib
1.2.7 Alectinib
1.2.8 Other
1.3 Market by Application
1.3.1 Global Oncology Targeted Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Targeted Therapy Market Perspective (2020-2031)
2.2 Global Oncology Targeted Therapy Growth Trends by Region
2.2.1 Global Oncology Targeted Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oncology Targeted Therapy Historic Market Size by Region (2020-2025)
2.2.3 Oncology Targeted Therapy Forecasted Market Size by Region (2026-2031)
2.3 Oncology Targeted Therapy Market Dynamics
2.3.1 Oncology Targeted Therapy Industry Trends
2.3.2 Oncology Targeted Therapy Market Drivers
2.3.3 Oncology Targeted Therapy Market Challenges
2.3.4 Oncology Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Targeted Therapy Players by Revenue
3.1.1 Global Top Oncology Targeted Therapy Players by Revenue (2020-2025)
3.1.2 Global Oncology Targeted Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Oncology Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oncology Targeted Therapy Revenue
3.4 Global Oncology Targeted Therapy Market Concentration Ratio
3.4.1 Global Oncology Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Targeted Therapy Revenue in 2024
3.5 Global Key Players of Oncology Targeted Therapy Head office and Area Served
3.6 Global Key Players of Oncology Targeted Therapy, Product and Application
3.7 Global Key Players of Oncology Targeted Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Targeted Therapy Breakdown Data by Type
4.1 Global Oncology Targeted Therapy Historic Market Size by Type (2020-2025)
4.2 Global Oncology Targeted Therapy Forecasted Market Size by Type (2026-2031)
5 Oncology Targeted Therapy Breakdown Data by Application
5.1 Global Oncology Targeted Therapy Historic Market Size by Application (2020-2025)
5.2 Global Oncology Targeted Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oncology Targeted Therapy Market Size (2020-2031)
6.2 North America Oncology Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oncology Targeted Therapy Market Size by Country (2020-2025)
6.4 North America Oncology Targeted Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Targeted Therapy Market Size (2020-2031)
7.2 Europe Oncology Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oncology Targeted Therapy Market Size by Country (2020-2025)
7.4 Europe Oncology Targeted Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Targeted Therapy Market Size (2020-2031)
8.2 Asia-Pacific Oncology Targeted Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oncology Targeted Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Oncology Targeted Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Targeted Therapy Market Size (2020-2031)
9.2 Latin America Oncology Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oncology Targeted Therapy Market Size by Country (2020-2025)
9.4 Latin America Oncology Targeted Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Targeted Therapy Market Size (2020-2031)
10.2 Middle East & Africa Oncology Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oncology Targeted Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Oncology Targeted Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Oncology Targeted Therapy Introduction
11.1.4 Bayer Revenue in Oncology Targeted Therapy Business (2020-2025)
11.1.5 Bayer Recent Development
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Eisai Business Overview
11.2.3 Eisai Oncology Targeted Therapy Introduction
11.2.4 Eisai Revenue in Oncology Targeted Therapy Business (2020-2025)
11.2.5 Eisai Recent Development
11.3 Zelgen
11.3.1 Zelgen Company Details
11.3.2 Zelgen Business Overview
11.3.3 Zelgen Oncology Targeted Therapy Introduction
11.3.4 Zelgen Revenue in Oncology Targeted Therapy Business (2020-2025)
11.3.5 Zelgen Recent Development
11.4 Cipla
11.4.1 Cipla Company Details
11.4.2 Cipla Business Overview
11.4.3 Cipla Oncology Targeted Therapy Introduction
11.4.4 Cipla Revenue in Oncology Targeted Therapy Business (2020-2025)
11.4.5 Cipla Recent Development
11.5 Natco Pharma
11.5.1 Natco Pharma Company Details
11.5.2 Natco Pharma Business Overview
11.5.3 Natco Pharma Oncology Targeted Therapy Introduction
11.5.4 Natco Pharma Revenue in Oncology Targeted Therapy Business (2020-2025)
11.5.5 Natco Pharma Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Oncology Targeted Therapy Introduction
11.6.4 AstraZeneca Revenue in Oncology Targeted Therapy Business (2020-2025)
11.6.5 AstraZeneca Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Oncology Targeted Therapy Introduction
11.7.4 Novartis Revenue in Oncology Targeted Therapy Business (2020-2025)
11.7.5 Novartis Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Oncology Targeted Therapy Introduction
11.8.4 Roche Revenue in Oncology Targeted Therapy Business (2020-2025)
11.8.5 Roche Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Oncology Targeted Therapy Introduction
11.9.4 Bristol-Myers Squibb Revenue in Oncology Targeted Therapy Business (2020-2025)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Oncology Targeted Therapy Introduction
11.10.4 Pfizer Revenue in Oncology Targeted Therapy Business (2020-2025)
11.10.5 Pfizer Recent Development
11.11 BEACON Pharma
11.11.1 BEACON Pharma Company Details
11.11.2 BEACON Pharma Business Overview
11.11.3 BEACON Pharma Oncology Targeted Therapy Introduction
11.11.4 BEACON Pharma Revenue in Oncology Targeted Therapy Business (2020-2025)
11.11.5 BEACON Pharma Recent Development
11.12 Jiangxi Shanxiang
11.12.1 Jiangxi Shanxiang Company Details
11.12.2 Jiangxi Shanxiang Business Overview
11.12.3 Jiangxi Shanxiang Oncology Targeted Therapy Introduction
11.12.4 Jiangxi Shanxiang Revenue in Oncology Targeted Therapy Business (2020-2025)
11.12.5 Jiangxi Shanxiang Recent Development
11.13 Yao Pharma
11.13.1 Yao Pharma Company Details
11.13.2 Yao Pharma Business Overview
11.13.3 Yao Pharma Oncology Targeted Therapy Introduction
11.13.4 Yao Pharma Revenue in Oncology Targeted Therapy Business (2020-2025)
11.13.5 Yao Pharma Recent Development
11.14 CSPC
11.14.1 CSPC Company Details
11.14.2 CSPC Business Overview
11.14.3 CSPC Oncology Targeted Therapy Introduction
11.14.4 CSPC Revenue in Oncology Targeted Therapy Business (2020-2025)
11.14.5 CSPC Recent Development
11.15 CHIATAI Tianqing
11.15.1 CHIATAI Tianqing Company Details
11.15.2 CHIATAI Tianqing Business Overview
11.15.3 CHIATAI Tianqing Oncology Targeted Therapy Introduction
11.15.4 CHIATAI Tianqing Revenue in Oncology Targeted Therapy Business (2020-2025)
11.15.5 CHIATAI Tianqing Recent Development
11.16 Simcere
11.16.1 Simcere Company Details
11.16.2 Simcere Business Overview
11.16.3 Simcere Oncology Targeted Therapy Introduction
11.16.4 Simcere Revenue in Oncology Targeted Therapy Business (2020-2025)
11.16.5 Simcere Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Bayer
Eisai Co Ltd
Zelgen
Cipla Ltd
Natco Pharma
Astrazeneca plc
Novartis
Roche
Bristol–Myers Squibb
Pfizer Inc
Beacon Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
Chiatai Tianqing
Simcere
List of Tables
 Table 1. Global Oncology Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Sorafenib
 Table 3. Key Players of Lenvatinib
 Table 4. Key Players of Regorafenib
 Table 5. Key Players of Osimertinib
 Table 6. Key Players of Anlotinib
 Table 7. Key Players of Alectinib
 Table 8. Key Players of Other
 Table 9. Global Oncology Targeted Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Oncology Targeted Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Oncology Targeted Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Oncology Targeted Therapy Market Share by Region (2020-2025)
 Table 13. Global Oncology Targeted Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Oncology Targeted Therapy Market Share by Region (2026-2031)
 Table 15. Oncology Targeted Therapy Market Trends
 Table 16. Oncology Targeted Therapy Market Drivers
 Table 17. Oncology Targeted Therapy Market Challenges
 Table 18. Oncology Targeted Therapy Market Restraints
 Table 19. Global Oncology Targeted Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Oncology Targeted Therapy Market Share by Players (2020-2025)
 Table 21. Global Top Oncology Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Targeted Therapy as of 2024)
 Table 22. Ranking of Global Top Oncology Targeted Therapy Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Oncology Targeted Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Oncology Targeted Therapy, Headquarters and Area Served
 Table 25. Global Key Players of Oncology Targeted Therapy, Product and Application
 Table 26. Global Key Players of Oncology Targeted Therapy, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Oncology Targeted Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Oncology Targeted Therapy Revenue Market Share by Type (2020-2025)
 Table 30. Global Oncology Targeted Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Oncology Targeted Therapy Revenue Market Share by Type (2026-2031)
 Table 32. Global Oncology Targeted Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Oncology Targeted Therapy Revenue Market Share by Application (2020-2025)
 Table 34. Global Oncology Targeted Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Oncology Targeted Therapy Revenue Market Share by Application (2026-2031)
 Table 36. North America Oncology Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Oncology Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Oncology Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Oncology Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Oncology Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Oncology Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Oncology Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Oncology Targeted Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Oncology Targeted Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Oncology Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Oncology Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Oncology Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Oncology Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Oncology Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Oncology Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Bayer Company Details
 Table 52. Bayer Business Overview
 Table 53. Bayer Oncology Targeted Therapy Product
 Table 54. Bayer Revenue in Oncology Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 55. Bayer Recent Development
 Table 56. Eisai Company Details
 Table 57. Eisai Business Overview
 Table 58. Eisai Oncology Targeted Therapy Product
 Table 59. Eisai Revenue in Oncology Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 60. Eisai Recent Development
 Table 61. Zelgen Company Details
 Table 62. Zelgen Business Overview
 Table 63. Zelgen Oncology Targeted Therapy Product
 Table 64. Zelgen Revenue in Oncology Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 65. Zelgen Recent Development
 Table 66. Cipla Company Details
 Table 67. Cipla Business Overview
 Table 68. Cipla Oncology Targeted Therapy Product
 Table 69. Cipla Revenue in Oncology Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 70. Cipla Recent Development
 Table 71. Natco Pharma Company Details
 Table 72. Natco Pharma Business Overview
 Table 73. Natco Pharma Oncology Targeted Therapy Product
 Table 74. Natco Pharma Revenue in Oncology Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 75. Natco Pharma Recent Development
 Table 76. AstraZeneca Company Details
 Table 77. AstraZeneca Business Overview
 Table 78. AstraZeneca Oncology Targeted Therapy Product
 Table 79. AstraZeneca Revenue in Oncology Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 80. AstraZeneca Recent Development
 Table 81. Novartis Company Details
 Table 82. Novartis Business Overview
 Table 83. Novartis Oncology Targeted Therapy Product
 Table 84. Novartis Revenue in Oncology Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 85. Novartis Recent Development
 Table 86. Roche Company Details
 Table 87. Roche Business Overview
 Table 88. Roche Oncology Targeted Therapy Product
 Table 89. Roche Revenue in Oncology Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 90. Roche Recent Development
 Table 91. Bristol-Myers Squibb Company Details
 Table 92. Bristol-Myers Squibb Business Overview
 Table 93. Bristol-Myers Squibb Oncology Targeted Therapy Product
 Table 94. Bristol-Myers Squibb Revenue in Oncology Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 95. Bristol-Myers Squibb Recent Development
 Table 96. Pfizer Company Details
 Table 97. Pfizer Business Overview
 Table 98. Pfizer Oncology Targeted Therapy Product
 Table 99. Pfizer Revenue in Oncology Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 100. Pfizer Recent Development
 Table 101. BEACON Pharma Company Details
 Table 102. BEACON Pharma Business Overview
 Table 103. BEACON Pharma Oncology Targeted Therapy Product
 Table 104. BEACON Pharma Revenue in Oncology Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 105. BEACON Pharma Recent Development
 Table 106. Jiangxi Shanxiang Company Details
 Table 107. Jiangxi Shanxiang Business Overview
 Table 108. Jiangxi Shanxiang Oncology Targeted Therapy Product
 Table 109. Jiangxi Shanxiang Revenue in Oncology Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 110. Jiangxi Shanxiang Recent Development
 Table 111. Yao Pharma Company Details
 Table 112. Yao Pharma Business Overview
 Table 113. Yao Pharma Oncology Targeted Therapy Product
 Table 114. Yao Pharma Revenue in Oncology Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 115. Yao Pharma Recent Development
 Table 116. CSPC Company Details
 Table 117. CSPC Business Overview
 Table 118. CSPC Oncology Targeted Therapy Product
 Table 119. CSPC Revenue in Oncology Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 120. CSPC Recent Development
 Table 121. CHIATAI Tianqing Company Details
 Table 122. CHIATAI Tianqing Business Overview
 Table 123. CHIATAI Tianqing Oncology Targeted Therapy Product
 Table 124. CHIATAI Tianqing Revenue in Oncology Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 125. CHIATAI Tianqing Recent Development
 Table 126. Simcere Company Details
 Table 127. Simcere Business Overview
 Table 128. Simcere Oncology Targeted Therapy Product
 Table 129. Simcere Revenue in Oncology Targeted Therapy Business (2020-2025) & (US$ Million)
 Table 130. Simcere Recent Development
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. Authors List of This Report


List of Figures
 Figure 1. Oncology Targeted Therapy Picture
 Figure 2. Global Oncology Targeted Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oncology Targeted Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Sorafenib Features
 Figure 5. Lenvatinib Features
 Figure 6. Regorafenib Features
 Figure 7. Osimertinib Features
 Figure 8. Anlotinib Features
 Figure 9. Alectinib Features
 Figure 10. Other Features
 Figure 11. Global Oncology Targeted Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 12. Global Oncology Targeted Therapy Market Share by Application: 2024 VS 2031
 Figure 13. Hospital Case Studies
 Figure 14. Retail Pharmacy Case Studies
 Figure 15. Other Case Studies
 Figure 16. Oncology Targeted Therapy Report Years Considered
 Figure 17. Global Oncology Targeted Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Oncology Targeted Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Oncology Targeted Therapy Market Share by Region: 2024 VS 2031
 Figure 20. Global Oncology Targeted Therapy Market Share by Players in 2024
 Figure 21. Global Top Oncology Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Targeted Therapy as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Oncology Targeted Therapy Revenue in 2024
 Figure 23. North America Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Oncology Targeted Therapy Market Share by Country (2020-2031)
 Figure 25. United States Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Oncology Targeted Therapy Market Share by Country (2020-2031)
 Figure 29. Germany Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Oncology Targeted Therapy Market Share by Region (2020-2031)
 Figure 37. China Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Oncology Targeted Therapy Market Share by Country (2020-2031)
 Figure 45. Mexico Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Oncology Targeted Therapy Market Share by Country (2020-2031)
 Figure 49. Turkey Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Oncology Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Bayer Revenue Growth Rate in Oncology Targeted Therapy Business (2020-2025)
 Figure 53. Eisai Revenue Growth Rate in Oncology Targeted Therapy Business (2020-2025)
 Figure 54. Zelgen Revenue Growth Rate in Oncology Targeted Therapy Business (2020-2025)
 Figure 55. Cipla Revenue Growth Rate in Oncology Targeted Therapy Business (2020-2025)
 Figure 56. Natco Pharma Revenue Growth Rate in Oncology Targeted Therapy Business (2020-2025)
 Figure 57. AstraZeneca Revenue Growth Rate in Oncology Targeted Therapy Business (2020-2025)
 Figure 58. Novartis Revenue Growth Rate in Oncology Targeted Therapy Business (2020-2025)
 Figure 59. Roche Revenue Growth Rate in Oncology Targeted Therapy Business (2020-2025)
 Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Oncology Targeted Therapy Business (2020-2025)
 Figure 61. Pfizer Revenue Growth Rate in Oncology Targeted Therapy Business (2020-2025)
 Figure 62. BEACON Pharma Revenue Growth Rate in Oncology Targeted Therapy Business (2020-2025)
 Figure 63. Jiangxi Shanxiang Revenue Growth Rate in Oncology Targeted Therapy Business (2020-2025)
 Figure 64. Yao Pharma Revenue Growth Rate in Oncology Targeted Therapy Business (2020-2025)
 Figure 65. CSPC Revenue Growth Rate in Oncology Targeted Therapy Business (2020-2025)
 Figure 66. CHIATAI Tianqing Revenue Growth Rate in Oncology Targeted Therapy Business (2020-2025)
 Figure 67. Simcere Revenue Growth Rate in Oncology Targeted Therapy Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Cancer Targeted Drug Market Research Report 2025
Global Targeted Small Molecule Drug Market Research Report 2025
Global Targeted Small Molecule Therapy Market Research Report 2025
Global Cancer Targeted Small Molecule Therapy Market Research Report 2025
Global Targeted Cancer Therapy Market Research Report 2024
Global Targeted Oncology Drugs Market Research Report 2024
Global Targeted Radiotherapy Drug Market Research Report 2024
Global Targeted Therapy for Breast Cancer Market Research Report 2025
Global Targeted Chemotherapy Drugs Market Research Report 2024
Global Personalized Cancer Medicine Market Research Report 2025
Molecular Targeted Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Targeted Therapy for Bladder Cancer Market Research Report 2025
Global Leukemia Targeted Therapy Drugs Market Research Report 2024
Global Small Molecule Targeted Cancer Therapy Market Research Report 2025
Cancer Treatment Drugs Market
Global Bladder Cancer Targeted Drug Market Research Report 2025
Global Targeted Antitumor Drugs Market Research Report 2025
Global Injectable Targeted Therapy Market Research Report 2024
Global Oncology Injection Drug Market Research Report 2025
Global Ovarian Cancer Targeted Therapy Drugs Market Research Report 2024

RELATED REPORTS

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global AI Contouring Software for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32T20006
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Cell Senescence β-Galactosidase Staining Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0Q20500
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Kinase Inhibitors For Cancer Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-18V16958
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions